ACH
AXDX

ArrowMark Colorado Holdings’s Accelerate Diagnostics AXDX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-68,463
Closed -$7.3M – 337
2020
Q3 		$7.3M Sell
68,463
-29,623
-30% -$4.11M 0.07% 178
2020
Q2 		$14.9M Sell
98,086
-7,334
-7% -$723K 0.15% 118
2020
Q1 		$8.78M Sell
105,420
-5,889
-5% -$829K 0.12% 145
2019
Q4 		$18.8M Buy
111,309
+2,818
+3% +$465K 0.17% 115
2019
Q3 		$20.1M Sell
108,491
-3,918
-3% -$757K 0.2% 103
2019
Q2 		$25.7M Buy
112,409
+1,397
+1% +$273K 0.25% 97
2019
Q1 		$23.3M Buy
111,012
+16,808
+18% +$3.15M 0.22% 104
2018
Q4 		$10.8M Buy
94,204
+24,752
+36% +$3.67M 0.11% 165
2018
Q3 		$15.9M Buy
69,452
+569
+0.8% +$126K 0.13% 144
2018
Q2 		$15.4M Buy
68,883
+4,764
+7% +$1.07M 0.14% 146
2018
Q1 		$14.7M Sell
64,119
-29,306
-31% -$7.7M 0.15% 143
2017
Q4 		$24.5M Buy
93,425
+7,377
+9% +$1.73M 0.25% 103
2017
Q3 		$19.3M Buy
86,048
+3,336
+4% +$819K 0.22% 105
2017
Q2 		$22.6M Buy
82,712
+2,122
+3% +$575K 0.28% 98
2017
Q1 		$19.5M Buy
80,590
+6,267
+8% +$1.43M 0.27% 98
2016
Q4 		$15.4M Buy
74,323
+5,977
+9% +$1.42M 0.24% 107
2016
Q3 		$18.6M Buy
68,346
+6,419
+10% +$1.42M 0.34% 95
2016
Q2 		$8.91M Buy
61,927
+15,151
+32% +$2.03M 0.18% 120
2016
Q1 		$6.72M Buy
46,776
+9,697
+26% +$1.37M 0.15% 128
2015
Q4 		$7.97M Buy
37,079
+15,546
+72% +$2.84M 0.22% 118
2015
Q3 		$3.48M Buy
21,533
+178
+0.8% +$38.5K 0.1% 167
2015
Q2 		$5.51M Buy
21,355
+1,500
+8% +$358K 0.13% 143
2015
Q1 		$4.47M Buy
+19,855
New +$4.15M 0.12% 146

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ArrowMark Colorado Holdings's AXDX Position: Q4 2020 in Review

ArrowMark Colorado Holdings sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 68,463 shares — an estimated $7.3M sold.

ArrowMark Colorado Holdings first reported a position in AXDX in Q1 2015 and held it in 23 quarters. The position peaked at $25.7M in Q2 2019. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

  • ArrowMark Colorado Holdings reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 68,463 Accelerate Diagnostics shares in Q4 2020, an estimated $7.3M.
  • ArrowMark Colorado Holdings first reported a position in Accelerate Diagnostics in Q1 2015 and held it in 23 quarters.
  • ArrowMark Colorado Holdings's Accelerate Diagnostics position peaked at $25.7M in Q2 2019.
  • 115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.